SynthesisWorld journal of urology2025
Robotic-assisted laparoscopic ureterocalicostomy (RALUC): a systematic review of its applications.
Synthesis in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeUreterocalicostomy refers to the anastomosis between the lower pole calyces and the ureter. Robotic-assisted laparoscopic ureterocalicostomy (RALUC) is gaining ground, ultimately. The current systematic review summarizes all applications of RALUC in both adults and children.
methodsIn line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Guidelines, three databases (PubMed, Scopus and Cochrane) were screened, from their inception to 16 February 2025. The following search string was used: robotic AND (ureterocalicostomy OR ureterocalicostomies OR ureterocalycostomy OR ureterocalycostomies).
resultsEight studies fulfilled all inclusion criteria and were finally considered for qualitative synthesis. The rate of patients who had undergone previous pyeloplasty ranged in included studies from 20% to 100%, while the rate of patients who had undergone a nephrostomy tube placement before the ureterocalicostomy ranged from 38% to 100%. Total operative time ranged from 157.6 (90-240) to 272 min, while estimated blood loss ranged from 27.5 (10-75) to 115 (50-200) mL. Reoperation rates ranged from 0% to 50%, while the success rates ranged from 66.7% to 100%. Finally, taking into consideration the Clavien-Dindo Classification System, the Grade I-II complications ranged from 0% to 40%, while the Grade III-IV ones ranged from 0% to 20%.
conclusionRALUC is a feasible, safe and efficient procedure for patients with complicated ureteropelvic junction obstruction. The implementation of higher-quality studies on larger samples, including comparative ones and randomized controlled trials, is crucial in order to draw safer conclusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.